Comparison clinical pharmacology NPA levodopa Parkinson disease Direct dopamine agonists effective levodopa symptoms Parkinson disease attempt situation acute motor responses intravenous injections dopamine agonist -N-n-propyl-norapomorphine hydrochloride NPA dopamine precursor levodopa optimum dose levels acute anti-Parkinsonian efficacy NPA maximum total symptom suppression levodopa patients amine precursor Dyskinesia severity similar drugs differences anti-Parkinsonian efficacy fact NPA dopamine receptors levodopa results stimulation subsets receptors physiological ratio Future efforts dopamine agonists treatment Parkinsonian symptoms drugs pharmacological profile similar dopamine 